Market Overview:
Beating heart patches are bioengineered extracellular matrix patches that are used to repair damaged heart muscles due to myocardial infarction. They help restore cardiac functions and improve viability of the heart muscle.
Market key trends:
One of the major trends driving the global beating heart patch market growth is the rising prevalence of cardiovascular diseases across the globe. According to World Health Organization (WHO), cardiovascular diseases accounted for approximately 17.9 million deaths in 2019, representing 32% of all global deaths. The increasing global burden of cardiovascular diseases has necessitated the need for innovative medical devices and therapies for treatment of heart conditions. This has propelled research and development of beating heart patches as an effective treatment option.
The global Beating Heart Patch Market Demand is estimated to be valued at US$ 223.6 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Segment Analysis
The global beating heart patch market is segmented into application and end user. By application, the allograft segment dominated the market in 2022. Allografts are preferred over xenografts and synthetic patches due to their ability to regenerate native tissues. By end user, the hospitals segment accounted for the largest share of the beating heart patch market in 2022. The high volume of cardiovascular procedures performed in hospitals is a major factor driving the segment's growth.
Key Takeaways
The global beating heart patch market size is expected to witness high growth, exhibiting a CAGR of 7.6% over the forecast period from 2023 to 2030, due to the increasing prevalence of cardiovascular diseases.
By region, North America dominated the global beating heart patch market in 2022 owing to high healthcare expenditure and established healthcare infrastructure in the region. Asia Pacific is projected to witness the fastest growth over the forecast period owing rising medical tourism and economic development in countries such as China and India.
Key players operating in the beating heart patch market are Harvard Apparatus Regenerative Technology, Inc., CorMatrix Cardiovascular, Inc., Acell Inc., Cytograft Tissue Engineering, Inc., Biomatrica, Inc., Tepha, Inc., LifeNet Health, Inc., CollPlant Ltd., SynCardia Systems, LLC, Cardiovascular Systems, Inc., Biotronik SE & Co. KG, Admedus Ltd., C. R. Bard, Inc., W. L. Gore & Associates, Inc., and Xenogenics Corporation. Major players are focusing on new product development and geographical expansion to strengthen their market position.
TheBusinessResearchCompany published its Cardiovascular Surgery Devices And Equipment Global Market Report 2019 which provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular surgery devices and equipment market.
The report covers the cardiovascular surgery devices and equipment market’s segments- beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposables.Explore Complete Report https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-reportCardiovascular Surgery Devices And Equipment Global Market Report 2019 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 50+ geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It covers all the regions, key developed countries and major emerging markets.
https://www.thebusinessresearchcompany.com/discounted-reports.aspxCompanies in the cardiovascular surgery devices and equipment market are investing in second generation bioresorbable stents and as well rectifying the glitches which occurred in the earlier version of bioresorbable stents.
A higher elective procedure volume due to the less-invasive nature of PCIs when compared to coronary artery bypass grafting is expected to drive bioresorbable stents adoption.Get Discount On This Report https://www.thebusinessresearchcompany.com/sample.aspx?id=2389=discountChapters from Table of Content:Chapter 1.
We put our heart and soul into every patch we help create.
We ensure every piece of leather patch is perfect quality, delivered on time and of course at affordable price.
Come and create Custom leather patch with us at EverLighten!
Bridgemed is committed to delivering cutting-edge treatment options for those suffering from cardiovascular disease.
Tissue patches can be shipped in as little as three days.
Get in touch with bridgemedsolutions for Tissue Patch for Heart Valve.https://www.bridgemedsolutions.com/tissue/
Gojek Clone App is the beating heart of this on-demand service industry.
It provides 70 plus services online through one single platform with such ease.
